BioSpace News Archive

Viatris, a global healthcare company, announced that it has packed 1,000 backpacks in partnership with Comfort Cases, a nonprofit organization that provides comfort and personal care items for children entering the foster care system.

Procaps Group announced a strategic leadership transition as Ruben Minski, founder and CEO of Procaps prepares to transition from the role of Chief Executive Officer to focus exclusively on his role as Executive Chairman of the Board, and the appointment of Jose Antonio Vieira as the new Chief Executive Officer of Procaps Group.

AnHeart Therapeutics and Innovent Biologics, Inc. today announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted a New Drug Application (NDA) for taletrectinib, a next-generation ROS1 tyrosine kinase inhibitor (TKI).

Sapphiros is proud to announce it has entered into a distribution agreement with Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation.

Lunit today announced that in a study recently published in European Radiology, Lunit’s AI-powered mammography analysis solution, Lunit INSIGHT MMG, has been validated for its effectiveness in standalone breast cancer detection.

CNS Pharmaceuticals, Inc. today announced the presentation of updated safety data from the ongoing potentially pivotal study evaluating Berubicin.

Novarad Corporation used VisAR, their augmented reality surgical navigation system, to biopsy an intraventricular tumor from a patient’s brain at MAC CDMX Hospital in Mexico this past week.

Algernon Pharmaceuticals Inc. is pleased to announce that it has signed a Letter of Intent (“LOI”) with Seyltx Inc. (“Seyltx”), a privately owned U.S. based drug development company, to acquire Algernon’s NP-120 (“Ifenprodil”) research program for USD $2M cash.

Elevation Oncology, Inc. today announced that Joseph J. Ferra , Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023, at 8:30 am ET.

Sagimet Biosciences Inc. today announced its participation in the upcoming 35th Annual Piper Sandler Healthcare Conference being held in New York.